Efficiency of Rifampin-loaded chitosan NPs in Killing of Brucella melitensis Isolated From Aborted Sheep in Wasit Province, Iraq

Author:

Sarhan R. Sarhan ,Shrooq J. Jassim ,Israa J. Jaber

Abstract

Brucellosis is consider one of the utmost common bacterial infectious illness that infect man and animals. unfortunately, A worldwide community in the developing country didn't provide active assistance for reducing it spread out globally. Therefore, the aim of this study is the synthesis of chitosan nanoparticles loaded with rifampin to overcome bacterial resistance and provide high intracellular penetration and the potential for potent intracellular antibacterial activity. The study was conducted from October 2019 to September 2021, Of 57 positive clinical specimens identified in the present study, 25 (65.78%), 20 (74.07%), and 12 (66.66%) were isolated from vaginal swabs, fetal membranes, and fetal abomasum contents, respectively. From the results of SEM images of NPs, it was clear that RIF-loaded CHNPs presented irregular surfaces or rough with spherical shape and presence of some particle aggregates. The RIF-CHNPs particle size observed using SEM images was 260.54 nm, while the diameter was 150.23 nm. In addition, the antibacterial activity were also measured and the results shows that the MIC values for RIF, CHNPs and RIF-CHNPs and they were 4, 2.5 and 0.625 ug/ml, respectively. While the EE % and DL % of RIF were measured spectrophotometrically. Loaded antibiotic formulation gave good percentage of entrapment efficiency and drug loading at concentration 50 mg/ml. Then the EE % at concentration 50 mg/ml was re-estimated in different pH values and the best EE% was at pH 5. In conclusion, the antibacterial activity of drug nanocarrier against B. melitensis found that it had a relatively low MIC 0.625 ug/ml. whereas the inhibitory concentrations were about 4 μg/ml and 2.5 μg/ml for the RIF and CHTNPs, respectively. Indicating there were 6.4 times reduction in MIC for RIF-CHTNPs and 1.6 time reduction for CHTNPs comparing to MIC of antibiotic alone.

Publisher

Siree Journals

Subject

Drug Discovery,Pharmaceutical Science,Pharmacology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3